Published in Transplant Rev (Orlando) on November 08, 2011
T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci U S A (2012) 0.85
Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells. Proc Natl Acad Sci U S A (2014) 0.85
The role of CARMA1 in T cells. Crit Rev Immunol (2013) 0.81
T cell-NF-κB activation is required for tumor control in vivo. J Immunother Cancer (2015) 0.80
MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway. Immunol Lett (2015) 0.75
The protein kinase C inhibitor sotrastaurin allows regulatory T cell function. Clin Exp Immunol (2014) 0.75
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Signaling to NF-kappaB. Genes Dev (2004) 19.78
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002) 13.86
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
Introduction to NF-kappaB: players, pathways, perspectives. Oncogene (2006) 7.78
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature (2010) 6.87
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature (2000) 5.48
NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev (2001) 4.70
The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 4.61
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol (2008) 4.33
Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest (2003) 4.14
Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature (2003) 3.96
The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med (2003) 3.85
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell (2001) 3.80
A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol (2001) 3.74
IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol (2005) 3.68
Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem (2004) 3.35
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell (1993) 3.35
A fourth IkappaB protein within the NF-kappaB signaling module. Cell (2007) 3.34
Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science (2010) 3.31
Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science (2003) 3.28
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J (1996) 2.68
The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity (2003) 2.67
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature (2002) 2.60
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci U S A (1992) 2.56
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (2010) 2.55
Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol (2003) 2.51
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science (1998) 2.46
TLR engagement prevents transplantation tolerance. Am J Transplant (2006) 2.36
TRAF6 is a critical factor for dendritic cell maturation and development. Immunity (2003) 2.36
Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity (2009) 2.35
Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity (2002) 2.31
Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med (2003) 2.30
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Mature T cells depend on signaling through the IKK complex. Immunity (2003) 2.21
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest (2005) 2.20
Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene (2001) 2.17
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
Different T cell receptor signals determine CD8+ memory versus effector development. Science (2009) 2.08
Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol (2009) 2.07
Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci U S A (2008) 2.05
Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res (2004) 1.99
The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. Proc Natl Acad Sci U S A (1993) 1.98
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J Biol Chem (1991) 1.92
Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J Exp Med (2004) 1.88
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2010) 1.88
Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med (1997) 1.85
c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med (2009) 1.85
Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol Cell (2006) 1.78
IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature (2010) 1.76
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature (2010) 1.68
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines. Blood (2005) 1.66
c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol (2003) 1.64
Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol Immunol (2008) 1.63
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J (1993) 1.61
Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity (1997) 1.56
Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells. Am J Transplant (2007) 1.55
Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg (2005) 1.52
NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J Immunol (2004) 1.51
A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol Cell Biol (1997) 1.50
Regulation of naive T cell function by the NF-kappaB2 pathway. Nat Immunol (2006) 1.49
Qualitative differences between naïve and memory T cells. Immunology (2002) 1.48
c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol (1999) 1.48
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation (2000) 1.43
Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol (2003) 1.41
The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity (2006) 1.40
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol (2009) 1.40
Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science (2007) 1.39
Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J Immunol (2006) 1.37
Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J Immunol (2004) 1.32
TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm (2010) 1.32
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol (2002) 1.32
Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia (2007) 1.27
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant. Proc Natl Acad Sci U S A (2006) 1.26
Abrogation of anti-HLA antibodies via proteasome inhibition. Transplantation (2009) 1.26
Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation. J Immunol (2005) 1.24
Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo. Mol Cell Biol (1996) 1.24
RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin-dependent interleukin-17 production in γδ T cells. Immunity (2011) 1.22
Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses. Proc Natl Acad Sci U S A (2005) 1.21
A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol (1998) 1.20
In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int (2004) 1.19
CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B. J Immunol (2007) 1.18
Induction of the NF-kappaB cascade by recruitment of the scaffold molecule NEMO to the T cell receptor. Immunity (2003) 1.18
Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli. Immunity (2010) 1.17
High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J Immunol (2011) 1.15
Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs. J Biol Chem (2001) 1.15
Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol (2009) 1.15
T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J Immunol (2003) 1.14
c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur J Immunol (2010) 1.14
TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J Immunol (2007) 1.10
Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant (2010) 1.07
Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ (2010) 1.03
Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol (2004) 1.03
The role of NF-kappaB and Smad3 in TGF-beta-mediated Foxp3 expression. Eur J Immunol (2009) 1.02
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood (2004) 1.01
Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J Biol Chem (2003) 1.01
Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol (2003) 5.47
GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev (2003) 2.97
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med (2006) 2.35
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest (2004) 1.71
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol (2009) 1.40
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol (2008) 1.30
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol (2002) 1.28
TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol (2009) 1.26
Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol (2008) 1.25
Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration. Mol Cell Biol (2004) 1.18
High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J Immunol (2011) 1.15
Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol (2004) 1.13
Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS One (2010) 1.09
Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells. Proc Natl Acad Sci U S A (2009) 1.06
The balance of immune responses: costimulation verse coinhibition. J Mol Med (Berl) (2005) 1.06
Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun (2014) 1.05
Secondary lymphoid organs are important but not absolutely required for allograft responses. Am J Transplant (2003) 1.04
The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol (2012) 1.03
Formation of a central supramolecular activation cluster is not required for activation of naive CD8+ T cells. Proc Natl Acad Sci U S A (2004) 1.03
TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. J Immunol (2002) 0.98
Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells. Proc Natl Acad Sci U S A (2009) 0.97
CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo. J Immunol (2003) 0.95
Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation (2010) 0.94
Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Am J Transplant (2003) 0.93
Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J Immunol (2004) 0.92
Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL. J Immunol (2005) 0.92
The composition of the microbiota modulates allograft rejection. J Clin Invest (2016) 0.88
Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev (2014) 0.86
T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci U S A (2012) 0.85
Bacterial infections, alloimmunity, and transplantation tolerance. Transplant Rev (Orlando) (2011) 0.85
Role of bacterial infections in allograft rejection. Expert Rev Clin Immunol (2008) 0.84
CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol (2002) 0.84
Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells. J Immunol (2002) 0.82
Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases. J Cutan Pathol (2008) 0.81
The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant (2015) 0.79
Role of T-cell-specific nuclear factor κB in islet allograft rejection. Transplantation (2012) 0.79
Fas mediates cardiac allograft acceptance in mice with impaired T-cell-intrinsic NF-kappaB signaling. Transpl Int (2009) 0.79
High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation (2016) 0.78
Lessons and limits of mouse models. Cold Spring Harb Perspect Med (2013) 0.78
Overexpression of program death-1 in T cells has mild impact on allograft survival. Transpl Int (2008) 0.77
CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients. JCI Insight (2017) 0.76
Transplantation tolerance after allograft rejection. Curr Opin Organ Transplant (2016) 0.75
Literature watch implications for transplantation. The anti-infectious role of the IL-17 pathway. Am J Transplant (2012) 0.75
The Multiple Molecular Paths of Antibody Suppression by TFR Cells. Am J Transplant (2017) 0.75
Super-MANF to the Rescue: Immunomodulation Improves Retinal Repair and Regenerative Cell Therapy. Am J Transplant (2017) 0.75
Dendritic Cell Identification for Dummies. Am J Transplant (2017) 0.75
Select Effects of IL-13 in Driving Tissue Repair and Fibrosis. Am J Transplant (2016) 0.75
Impact of environmental factors on alloimmunity and transplant fate. J Clin Invest (2017) 0.75
Standardizing Mouse Models to Account for Host-Microbial Interactions. Am J Transplant (2016) 0.75
Innate lymphoid cells coming of age. Am J Transplant (2019) 0.75
The Unbearable Lightness of Breathing. Am J Transplant (2017) 0.75
Germ Warfare. Sci Am (2016) 0.75
Immune-Electrical Connection. Am J Transplant (2017) 0.75
Predicting TCR specificity? Am J Transplant (2017) 0.75
The Bugs That Keep Us Safe. Am J Transplant (2017) 0.75
Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans. Transplantation (2017) 0.75
Timing Is Everything. Am J Transplant (2017) 0.75
Making Therapeutic Antibodies in Vitro. Am J Transplant (2017) 0.75
Stealing Tregs' Identity (by Deleting NF-κB). Am J Transplant (2017) 0.75
Ionic Checkpoint: Potassium-Driven T Cell Immunosuppression. Am J Transplant (2016) 0.75
The Tpm Subset of the CD8(+) T Cell Memory Family. Am J Transplant (2017) 0.75
Anti-Inflammatory Effects of Nonprofessional Phagocyte. Am J Transplant (2017) 0.75